Baclofen - Isotope Labelled Standards
References
FAQ's
References
- Degen, P. H.; Riess, W., The determination of γ-amino-β-(p-chlorophenyl)butyric acid (baclofen) in biological material by gas-liquid chromatography, Journal of Chromatography, Volume: 117, Issue: 2, Pages: 399-405, 1976
- Harrison, P. M.; Tonkin, A. M.; McLean, A. J., Determination of 4-amino-3-(p-chlorophenyl)butyric acid (baclofen) in plasma by high-performance liquid chromatography, Journal of Chromatography, Biomedical Applications, Volume: 339, Issue: 2, Pages: 424-8, 1985
Frequently Asked Questions
Are all Baclofen impurities harmful to health?
Not all Baclofen impurities are harmful to health, but their presence can affect the quality and purity of the drug product, and some may pose a risk to patient health.
Can impurities in Baclofen be eliminated?
Complete elimination of impurities in Baclofen is not possible. However, a reduction in their levels to acceptable limits is through purification and quality control procedures.
How can the quality of Baclofen be ensured during storage and transportation?
The quality of Baclofen can be ensured during storage and transportation by following proper storage conditions such as temperature and humidity control and using appropriate packaging materials.
What are the temperature conditions required to store Baclofen impurities?
Baclofen impurities are stored at a controlled room temperature between 2-8 °C or as indicated on the Certificate of Analysis (CoA).
Note: Products protected by valid patents by a manufacturer are not offered for sale in countries having patent protection. The sale of such products constitutes a patent infringement, and its liability is at the buyer's risk.